|
|
| 61.69 Data as of Mar 04 |  0.00 / 0.00%Today’s Change | 48.00 Today|||52-Week Range 61.69 | +7.66% Year-to-Date |
| Was Medivation's Quarter a Disaster? Mar 03 / MotleyFool.com | Medivation Swings to Earnings in Q4 - Analyst Blog Feb 28 / Zacks.com |
| Previous close | 61.69 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 1,201 |
| Market cap | $28.2B |
| Dividend yield | 2.13% |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
.
